7 Biotechs With Catalysts in the Next Month
Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the rest of September and in October.
All Work
Chris Lange
Wedbush’s Top Picks in the Observability Tech Field
The term “observability” is being used to describe next-generation approaches to observing and troubleshooting complex distributed systems with high cardinality of its various entities and a high potential for “unknown-unknowns” to affect their operation.
Analyst Sees Big Upside in Nuance Communications After the Spin-Off
Nuance Communications is planning to spin off its auto business into a new public company, Cerence, which will begin trading on October 1. Ahead of this spin-off, Wedbush met with executives to discuss what…
Why This Analyst Is Still on the Sidelines About Oracle
Oracle kicked off its analyst meeting by reiterating its expectations for revenues. The main theme of this day is that Oracle is “putting all the pieces together to enable customers to be successful in…
Friday’s Top Analyst Upgrades and Downgrades: Apple, Aurora Cannabis, Constellation Brands, Etsy, Marathon Oil, Roku, Square, Tilray and More
The top analyst upgrades, downgrades and initiations for Friday included Apple, Aurora Cannabis, Constellation Brands, Etsy, Marathon Oil, Roku, Square and Tilray.
Ping Identity: Another Red-Hot IPO
Software company Ping Identity was another IPO that had an incredible Thursday, with its shares entering the market well above the announced pricing.
Datadog Enters the Market With a Bang
Cloud monitoring firm Datadog entered the markets with a bang on Thursday, above the expected price range.
More Millennials Are Shopping for Credit Cards
Millennials make up a huge portion of consumers in the U.S economy, and with all this spending, millennials are flocking to credit cards.
What’s in the Mix for Beyond Meat?
Beyond Meat shares have backed off from their incredible run over the summer. This comes as more businesses are coming around to the idea of faux meat and more competitors are emerging on the…
US Steel Gets Burned by Updated Guidance
U.S. Steel shares dropped sharply on Thursday after the firm cut the guidance for its third quarter. Looking at the chart, it’s not surprising that this stock is headed even lower, after falling nearly…
Darden Retaurants’ Earnings: All Sizzle, No Steak
Darden Restaurants shares pulled back after it released mixed fiscal first-quarter financial results before the markets opened on Thursday.
Thursday’s Top Analyst Upgrades and Downgrades: Beyond Meat, US Steel, Check Point Software, Applied Materials, AutoZone, Costco and More
The top analyst upgrades, downgrades and initiations for Thursday included Beyond Meat, U.S. Steel, Check Point Software, Applied Materials, AutoZone and Costco Wholesale.
What to Expect When Darden Reports Thursday
Darden Restaurants is scheduled to release its fiscal first quarter financial results before the markets open on Thursday. The consensus estimates are calling for $1.36 in earnings per share (EPS) and $2.14 billion in…
Why China Could Bring the Upside Surprise for Apple and the iPhone 11
Apple is on the verge of releasing its newest generation of iPhone. While the United States is a huge market for Apple, China could play an even bigger role this year, according to one…
Wall Street Tries to Look Past FedEx’s Worst Day Since Financial Crisis
FedEx reported its most recent quarterly results after the markets closed on Tuesday. While the actual earnings from the quarter were not that bad, guidance is what really pulled shares down.
Is a Recession on the Horizon? CFOs Grow More Pessimistic
While U.S. markets are holding near all-time highs, the concerns about recession seem to be mounting. The Duke University quarterly survey of CFO Global Business Outlook gave some credence to this sentiment.
CDW Set to Break Into the S&P 500
CDW shares jumped on Wednesday after the firm announced that it would replace Total System Services in the S&P 500.
Is This Epilepsy Cannabinoid Treatment Really in Trouble?
Zynerba Pharmaceuticals has announced positive results from its midstage epilepsy trial, and yet its shares dropped on Wednesday.
Will This Ebola Vaccine Be the Next Big Thing?
NewLink Genetics shares jumped on Wednesday after the firm announced that the FDA has accepted Merck’s Biologics License Application and granted priority review for the investigational Ebola vaccine.
Why Adobe’s Record Quarter Wasn’t Enough for Investors
Adobe released better than expected fiscal third-quarter earnings report after the markets closed on Tuesday.